Key result
Severe early-onset androgenetic alopecia is linked to higher metabolic syndrome prevalence in young men.
Why the study?
Very few studies have focused on the early development of MetS in younger males and its association with the severity of AGA.
Cross-Sectional (n=100)
No
Young men with early-onset androgenetic alopecia have a high prevalence of metabolic syndrome, suggesting a need for early cardiovascular risk screening in this population.
Answers are grounded in this paper and cite their sources.
Early-onset androgenetic alopecia associated with metabolic syndrome in young men; hypothesis-generating and should not yet change screening practice.
Background: Androgenetic alopecia (AGA), although considered medically benign, has been found to be associated with increased cardiovascular risk, especially in patients with early onset (≤ 30 years). Metabolic syndrome (MetS) comprises a cluster of cardiovascular risk factors predicting morbidity. Very few studies focused on early development of MetS in younger males and the association with the severity of AGA, necessitating further research. Objectives: To estimate the prevalence of MetS in men with early-onset AGA and to assess if there is a positive correlation between the severity of AGA and the development of MetS and its components. Materials and Methods: A cross-sectional study was undertaken in a tertiary care hospital from November 2020 to October 2022, on men in the age group of 18 - 40 years. 100 men with early-onset AGA (≤ 30 years) were included in the study. MetS was diagnosed as per the criteria by the International Diabetes Federation (IDF), and American Heart Association/ National Heart, Lung and Blood Institute (AHA/NHLBI). Chi-square test and student's t-test were used for statistical analysis. Results: Metabolic syndrome was diagnosed in 63 (63%) of the patients. The prevalence of MetS (P = 0.006), elevated waist circumference (P = 0.006), elevated serum triglycerides (P = 0.011), and mean value of serum high-density lipoprotein (P = 0.05) was statistically significant in patients with severe AGA. Conclusion: A high prevalence of metabolic syndrome was found in young males with early-onset AGA. Screening and lifestyle modifications should be enforced earlier to lessen cardiovascular morbidity and mortality in young male patients with AGA.
No takes yet. Share an insight, caveat, or question.
Majella et al. (2025) conducted a cross-sectional in Early-onset Androgenetic Alopecia (n=100). Severe androgenetic alopecia vs. Non-severe androgenetic alopecia was evaluated on Metabolic syndrome (p=0.006). Severe early-onset androgenetic alopecia in young men was significantly associated with a higher prevalence of metabolic syndrome (P=0.006), which was present in 63% of the overall study population.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: